Although the underlying causes of the condition aren't totally clear, certain triggers that exacerbate symptoms are well-known, though they differ from person to person
ChemBioChem 12:3842 Tyagi A, Tuknait A, Anand P, Gupta S, Sharma M, Mathur D, Joshi A, Singh S, Gautam A et al (2015) CancerPPD: a database of anticancer peptides and proteins
Anti-PCSK9 antibodies, such as evolocumab and alirocumab, block the PCSK9 interaction with LDL receptor and have demonstrated robust LDL-C reductions in hypercholesterolemic patients 8
Keep realistic expectations and measure at twelve weeks
1 2 3 4 5 6 Pharmacology & Therapeutics
Long haul COVID-19, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), is a condition where individuals experience persistent symptoms and health issues following a COVID-19 infection